GlaxoSmithKline PLC
XETRA:GS7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
GlaxoSmithKline PLC
XETRA:GS7
|
UK |
|
Investore Property Ltd
NZX:IPL
|
NZ |
|
C
|
Charles River Laboratories International Inc
XMUN:RV6
|
US |
|
Nomura Real Estate Holdings Inc
F:N9U
|
JP |
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
ID |
|
E
|
Everbright Securities Co Ltd
HKEX:6178
|
CN |
|
A
|
AG Mortgage Investment Trust Inc
F:8AGA
|
US |
|
O
|
Outlook Therapeutics Inc
SWB:41ON
|
US |
|
F
|
Fast Retailing Co Ltd
DUS:FR7
|
JP |
|
H
|
Hackett Group Inc
DUS:AWT
|
US |
|
F
|
Fresenius SE & Co KGaA
DUS:FRE
|
DE |
Dividends
Dividend Yield
GlaxoSmithKline PLC
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
GlaxoSmithKline PLC
GS7 have decreased by 0%.
Payout Ratio
GlaxoSmithKline PLC
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for GS7 is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
GS7 Price
GlaxoSmithKline PLC
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -29% |
| Market Capitalization | 74.7B EUR |
| Shares Outstanding | 4 067 350 016 |
| Percentage of Shares Shorted |
N/A
|
